1 – 10 of 43
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Targeting TUBG1 in RB1-negative tumors
2025) In FASEB journal : official publication of the Federation of American Societies for Experimental Biology 39(5).(
- Contribution to journal › Article
- 2022
-
Mark
Alternative splicing encodes functional intracellular CD59 isoforms that mediate insulin secretion and are down-regulated in diabetic islets
(
- Contribution to journal › Article
- 2015
-
Mark
Therapeutic Targeting of Nuclear Gamma-Tubulin in RB1-negative Tumors.
(
- Contribution to journal › Article
-
Mark
Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients.
(
- Contribution to journal › Article
- 2013
-
Mark
Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation
(
- Contribution to journal › Article
- 2012
-
Mark
Analysis of binding sites on complement factor I using artificial N-linked glycosylation.
(
- Contribution to journal › Article
- 2010
-
Mark
Analysis of binding sites on complement Factor I that are required for its activity
(
- Contribution to journal › Published meeting abstract
-
Mark
Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I
(
- Contribution to journal › Article
-
Mark
Analysis of binding sites on complement factor I that are required for its activity.
(
- Contribution to journal › Article
-
Mark
Tensin2 reduces intracellular phosphatidylinositol 3,4,5-trisphosphate levels at the plasma membrane.
(
- Contribution to journal › Article